Comparative evaluation of the safety and efficacy of long term use of anti-cholinergic, Imidafenacin and Solifenacin, on overactive bladder: a prospective randomized trial.
Not Applicable
- Conditions
- overactive bladder
- Registration Number
- JPRN-UMIN000004354
- Lead Sponsor
- Department of Urology, Kanto Rosai Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1)Contraindication to anti-cholinergic agents. (Primary angle-closure glaucoma , urinary retention , Obstructive intestinal disease, paralytic ileus, gastrointestinal atony, myastania gravis) 2)Residual urine >=100mL. 3)Suspect of prostate cancer. 4)Active urinary tract infection. 5)Judged as being unsuitable for the trial by the researcher.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1)OABSS 2)Side effects(dry mouth, constipation, vision blurred etc)
- Secondary Outcome Measures
Name Time Method 1)King's Health Questionnaire 2)QTc interval 3)Residual urine volume